Tiny gas-filled spheres known as nanobubbles are now attracting growing attention in the medical world for their potential to help alleviate autoimmune symptoms. For many people living with autoimmune diseases, daily life is often marked by persistent pain, fatigue, and inflammation that are difficult to control. The oxygen-hydrogen nanobubble technology — ultra-small gas bubbles — offers a promising new approach to support the management of these conditions. But how exactly can these microscopic bubbles help improve the quality of life for autoimmune patients?

Oxygen-hydrogen nanobubbles are extremely small gas bubbles, typically measuring tens to hundreds of nanometers, that can contain hydrogen (H₂) or oxygen (O₂) and possess high stability due to protective molecular layers on their surface. Unlike ordinary bubbles that burst quickly, nanobubbles remain stable in liquids and gradually release their gas content. Their nano size allows them to penetrate tissues and tiny blood vessels, reaching areas of the body that are oxygen-deprived due to inflammation or metabolic imbalance. When consumed or used therapeutically, nanobubbles act as carriers of therapeutic gases: hydrogen helps neutralize harmful free radicals and suppress inflammation, while oxygen boosts tissue oxygenation and supports cell function and resilience.

The Role of Hydrogen and Oxygen Nanobubbles in Autoimmune Conditions

In autoimmune diseases, the immune system — which normally protects the body — mistakenly attacks its own cells and tissues. This triggers chronic inflammation that continuously damages tissues and produces inflammatory molecules such as IL-6, TNF-α, and IL-1β. The condition is often accompanied by an increase in free radicals that cause oxidative stress, leading to further cell damage. Over time, this process hampers the body’s ability to heal and causes persistent fatigue as mitochondria — the cell’s energy producers — become less efficient. Additionally, inflamed tissues often suffer from oxygen deficiency, which worsens damage and amplifies the cycle of inflammation.

Hydrogen and oxygen nanobubbles help interrupt this cycle. Hydrogen acts as a natural antioxidant that neutralizes the most harmful free radicals without interfering with essential biological processes. It also reduces the production of inflammatory molecules and helps restore balance in an overactive immune system. With fewer free radicals and less inflammation, tissue damage can slow down and cellular function can improve. Meanwhile, oxygen nanobubbles provide additional oxygen to oxygen-deprived tissues, allowing cells to produce energy more efficiently. Oxygen also supports healing and tissue repair that are often hindered by chronic inflammation. When used together, the two types of nanobubbles complement each other: hydrogen helps calm inflammation and oxidative stress, while oxygen enhances metabolism and strengthens cell function. This combination may help autoimmune patients achieve a more stable and balanced physiological state.

Finally, it is important to note that nanobubbles are not a replacement for conventional medical treatment. Autoimmune patients typically undergo medication-based therapies such as corticosteroids or immunosuppressants, which have proven effective in controlling the disease. At present, oxygen-hydrogen nanobubbles serve as an adjunct therapy designed to help relieve symptoms or reduce side effects. Until stronger scientific evidence becomes available, patients are advised to continue following medical guidance and to view nanobubble therapy as an innovative complement — not a substitute — for standard treatment.

Source:

• Today’s Practitioner. (2020, September 10). Hydrogen: An intriguing agent to address autoimmunity. Today’s Practitioner. https://todayspractitioner.com/hydrogen/hydrogen-an-intriguing-agent-to-address-autoimmunity/#:~:text=Participants%20were%20instructed%20to%20bathe,or%20discontinue%20their%20medication%20use

•  Hamzah H, Suryanti S, Ahmed IA et al. Review the role of oxygen-delivering nanobubbles in stroke therapy: A novel approach [version 3; peer review: 2 approved]. F1000Research 2025, 14:406 (https://doi.org/10.12688/f1000research.162742.3)

• Garcia, S. M. V., Khan, M. S., Haidar, Z. S., & Cox, J. P. A. (2023). NanoBubble-Mediated Oxygenation: Elucidating the underlying molecular mechanisms in hypoxia and Mitochondrial-Related pathologies. Nanomaterials, 13(23), 3060. https://doi.org/10.3390/nano13233060